Your browser doesn't support javascript.
loading
The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases.
Alenius, Harri; Sinkko, Hanna; Moitinho-Silva, Lucas; Rodriguez, Elke; Broderick, Conor; Alexander, Helen; Reiger, Matthias; Hjelmsø, Mathis Hjort; Fyhrquist, Nanna; Olah, Peter; Bryce, Paul; Smith, Catherine; Koning, Frits; Eyerich, Kilian; Greco, Dario; van den Bogaard, Ellen H; Neumann, Avidan U; Traidl-Hoffmann, Claudia; Homey, Bernhard; Flohr, Carsten; Bønnelykke, Klaus; Stokholm, Jakob; Weidinger, Stephan.
Affiliation
  • Alenius H; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Sinkko H; Human Microbiome Research Program (HUMI), Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Moitinho-Silva L; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Rodriguez E; Human Microbiome Research Program (HUMI), Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Broderick C; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Alexander H; Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Reiger M; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Hjelmsø MH; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Fyhrquist N; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Olah P; Department of Environmental Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Bryce P; Institute of Environmental Medicine, Helmholtz Zentrum München, Augsburg, Germany.
  • Smith C; Chair of Environmental Medicine, Technical University Munich, Munich, Germany.
  • Koning F; COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Eyerich K; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Greco D; Department of Dermatology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • van den Bogaard EH; Department of Dermatology, Venereology and Oncodermatology, Medical Faculty, University of Pécs, Pécs, Hungary.
  • Neumann AU; Type 2 Inflammation & Fibrosis Cluster, Immunology & Inflammation Therapeutic Area, Sanofi US, Cambridge, Massachusetts, USA.
  • Traidl-Hoffmann C; Kings College London, and Guys and St Thomas' NHS Foundation Trust, Guy's Hospital, St John's Institute of Dermatology, London, UK.
  • Homey B; Department of Immunology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.
  • Flohr C; Department of Medicine, Karolinska Institutet, Solna, Sweden.
  • Bønnelykke K; Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
  • Stokholm J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Weidinger S; Department of Dermatology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Exp Dermatol ; 30(10): 1517-1531, 2021 10.
Article in En | MEDLINE | ID: mdl-34387406

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Skin / Dermatitis, Atopic / Microbiota Type of study: Prognostic_studies Limits: Humans Language: En Journal: Exp Dermatol Journal subject: DERMATOLOGIA Year: 2021 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Skin / Dermatitis, Atopic / Microbiota Type of study: Prognostic_studies Limits: Humans Language: En Journal: Exp Dermatol Journal subject: DERMATOLOGIA Year: 2021 Type: Article Affiliation country: Sweden